Bonus Biogroup Stock Price Patterns
| BBIXF Stock | USD 0.09 0.01 10.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Bonus BioGroup hype-based prediction, you can estimate the value of Bonus BioGroup from the perspective of Bonus BioGroup response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bonus BioGroup to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Bonus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bonus BioGroup after-hype prediction price | USD 0.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bonus |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bonus BioGroup's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bonus BioGroup After-Hype Price Density Analysis
As far as predicting the price of Bonus BioGroup at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bonus BioGroup or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bonus BioGroup, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bonus BioGroup Estimiated After-Hype Price Volatility
In the context of predicting Bonus BioGroup's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bonus BioGroup's historical news coverage. Bonus BioGroup's after-hype downside and upside margins for the prediction period are 0.00 and 13.58, respectively. We have considered Bonus BioGroup's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bonus BioGroup is out of control at this time. Analysis and calculation of next after-hype price of Bonus BioGroup is based on 3 months time horizon.
Bonus BioGroup Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Bonus BioGroup is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bonus BioGroup backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bonus BioGroup, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.82 | 13.49 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.09 | 0.09 | 0.00 |
|
Bonus BioGroup Hype Timeline
Bonus BioGroup is currently traded for 0.09. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bonus is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.82%. %. The volatility of related hype on Bonus BioGroup is about 0.0%, with the expected price after the next announcement by competition of 0.09. About 50.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days. Check out Bonus BioGroup Basic Forecasting Models to cross-verify your projections.Bonus BioGroup Related Hype Analysis
Having access to credible news sources related to Bonus BioGroup's direct competition is more important than ever and may enhance your ability to predict Bonus BioGroup's future price movements. Getting to know how Bonus BioGroup's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bonus BioGroup may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SPHRF | Starpharma Holdings Limited | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 45.54 | |
| FNCH | Finch Therapeutics Group | 0.00 | 0 per month | 1.59 | (0.01) | 3.21 | (3.44) | 8.64 | |
| RVXCF | Resverlogix Corp | 0.00 | 0 per month | 5.26 | 0.03 | 14.29 | (12.50) | 34.29 | |
| CLYYF | Celyad Oncology SA | 0.00 | 0 per month | 0.00 | (0.19) | 0.00 | 0.00 | 16.67 | |
| MRES | Institute of Biomedical | 0.00 | 0 per month | 15.20 | 0.04 | 47.22 | (28.21) | 111.97 | |
| ELVAF | Evolva Holding SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CLIFF | Cordlife Group Limited | 0.00 | 0 per month | 0.00 | (0.09) | 0.00 | 0.00 | 42.09 | |
| ZHCLF | Zenith Capital Corp | 0.00 | 0 per month | 71.93 | 0.25 | 16,567 | (78.57) | 30,000 | |
| IPDQF | ImpediMed Limited | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 128.75 | |
| CLCS | Cell Source | 0.00 | 0 per month | 4.38 | 0.23 | 12.50 | (9.09) | 31.62 |
Bonus BioGroup Additional Predictive Modules
Most predictive techniques to examine Bonus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bonus using various technical indicators. When you analyze Bonus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bonus BioGroup Predictive Indicators
The successful prediction of Bonus BioGroup stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bonus BioGroup, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bonus BioGroup based on analysis of Bonus BioGroup hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bonus BioGroup's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bonus BioGroup's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Bonus Pink Sheet analysis
When running Bonus BioGroup's price analysis, check to measure Bonus BioGroup's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonus BioGroup is operating at the current time. Most of Bonus BioGroup's value examination focuses on studying past and present price action to predict the probability of Bonus BioGroup's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonus BioGroup's price. Additionally, you may evaluate how the addition of Bonus BioGroup to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |